HEALTH CATALYST INC (HCAT) Stock News
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
HCAT Latest News, Press Relases and Analysis
Health Catalyst (HCAT) Reports Earnings Tomorrow: What To Expect
Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting earnings tomorrow after the bell. Here’s what you need to know.
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations
/PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
Health Catalyst Announces ~$5 Million Stock Repurchase
/PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™
/PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
3 Small-Cap Stocks in Hot Water
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (
1 Software Stock with Exciting Potential and 2 to Ignore
From commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over the last six months, the industry’s 14.2% return has topped the S&P 500 by 9.2 percentage points.
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™
/PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare...
Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year
Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6% year on year to $79.61 million. On the other hand, next quarter’s revenue guidance of $79 million was less impressive, coming in 3.5% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was 47.6% below analysts’ consensus estimates.
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024.
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025
Health Catalyst to Participate in Upcoming Investor Conference
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.